Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

Haematologica

Volumn 96, Issue 8, 2011, Pages 1231-1235

  Ljungman, Per ^a   de la Camara, Rafael ^b   Perez Bercoff, Lena ^a   Abecasis, Manuel ^c   Campuzano, Jose Bartolo Nieto ^d   Cannata Ortiz, M Jimena ^b   Cordonnier, Catherine ^e   Einsele, Hermann ^f   Gonzalez Vicent, Marta ^g   Espigado, Ildefonso ^h   Halter, Jörg ⁱ   Martino, Rodrigo ^j   Mohty, Bilal ^k   Sucak, Gülsan ^l   Ullmann, Andrew J ^m   Vázquez, Lourdes ⁿ   Ward, Katherine N ^o   Engelhard, Dan ^p  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^d HOSPITAL MORALES MESEGUER   (Spain)

^e HENRI MONDOR HOSPITAL   (France)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^k UNIVERSITY HOSPITAL   (Switzerland)

^l GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^m JOHANNES GUTENBERG UNIVERSITY   (Germany)

ⁿ HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^o UNIVERSITY COLLEGE LONDON   (United Kingdom)

^p HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

more..

Author keywords

H1n1; Hsct; Influenza; Pandemic

Indexed keywords

2009 H1N1 INFLUENZA VACCINE; INFLUENZA VACCINE; OSELTAMIVIR; UNCLASSIFIED DRUG; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CONTROLLED STUDY; DEATH; GRAFT RECIPIENT; HOSPITAL PATIENT; HUMAN; INFANT; INFECTION RISK; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; NEUTROPENIA; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LYMPHOPENIA; MIDDLE AGED; OSELTAMIVIR; PANDEMICS; PNEUMONIA; RISK FACTORS; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 79961058536     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.041913     Document Type: Article

References (24)

1. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. The New Engl J Med. 2010;362(18):1708-19.
2. Hajjar LA, Mauad T, Galas FR, Kumar A, da Silva LF, Dolhnikoff M, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol. 2010;21(12):2333-41.
3. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010;10(8):521-6.
4. Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M. Differences in clinical outcomes following 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood. 2011;117(19):5050-6.
5. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infect- ious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28(5):479-84.
6. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39(9):1300-6.
7. Whimbey E, Elting LS, Couch RB, Lo W, Williams L, Champlin RE, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 1994;13(4):437-40.
8. Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009;44(8):521-6.
9. Kumar D, Morris MI, Kotton CN, Fischer SA, Michaels MG, Allen U, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant. 2010;10(1):18-25.
10. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant. 1993;11(1):1-5.
11. Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G, et al. Granulo- cyte-macrophage colony-stimulating factoras immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis. 2000;30(2):342-8.
12. Yalcin SS, Kondolot M, Albayrak N, Altas AB, Karacan Y, Kuskonmaz B, et al. Serological response to influenza vaccine after hematopoetic stem cell transplantation. Ann Hematol. 2010;89(9):913-8.
13. Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, et al. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Vaccine. 2011;29(9):1777-82.
14. Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust. 2010;192(2):84-6.
15. Machado CM, Boas LS, Mendes AV, da Rocha IF, Sturaro D, Dulley FL, et al. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant. 2004;34(2):111-4.
16. Besselaar TG, Naidoo D, Buys A, Gregory V, McAnerney J, Manamela JM, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis. 2008;14(11):1809-10.
17. Gratwohl A, Brand R, Apperley J, Crawley C, Ruutu T, Corradini P, et al. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplant- ation (EBMT). Haematologica. 2006;91(4): 513-21.
18. Launes C, Rives S, Catala A, Berrueco R, Toll T, Camos M, et al. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. British J Haematol. 2010;149(6):874-8.
19. Caselli D, Carraro F, Castagnola E, Ziino O, Frenos S, Milano GM, et al. Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer. 2010;55(2): 226-8.
20. Janies DA, Voronkin IO, Studer J, Hardman J, Alexandrov BB, Treseder TW, et al. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages. Int J Health Geogr. 2010;9:13.
21. Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010;16(7):1068-75.
22. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Com- mittee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62.
23. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, Cruz-Hervert P, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ. 2009;339:b3928.
24. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361(20):1945-52.